Ogen 0.625 Interactions
There are 234 drugs known to interact with Ogen 0.625 (estropipate), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 17 are major, 198 are moderate, and 19 are minor.
- View all 234 medications that may interact with Ogen 0.625
- View Ogen 0.625 alcohol/food interactions (3)
- View Ogen 0.625 disease interactions (17)
Most frequently checked interactions
View interaction reports for Ogen 0.625 (estropipate) and the medicines listed below.
- Adipex-P (phentermine)
- Amerge (naratriptan)
- aspirin
- Aspirin Low Strength (aspirin)
- Boniva (ibandronate)
- Calcium 600 D (calcium / vitamin d)
- Cymbalta (duloxetine)
- Desyrel (trazodone)
- Fiber Laxative (polycarbophil)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flax Seed Oil (flax)
- Flexeril (cyclobenzaprine)
- hydrochlorothiazide
- ibuprofen
- isosorbide mononitrate
- Lipitor (atorvastatin)
- lisinopril
- magnesium oxide
- metoprolol
- multivitamin
- Norco (acetaminophen / hydrocodone)
- pantoprazole
- Prilosec (omeprazole)
- Prograf (tacrolimus)
- Provera (medroxyprogesterone)
- Restoril (temazepam)
- Salagen (pilocarpine)
- Tylenol PM (acetaminophen / diphenhydramine)
- Vitamin Daily Liquid (multivitamin)
- Voltaren (diclofenac)
Ogen 0.625 alcohol/food interactions
There are 3 alcohol/food interactions with Ogen 0.625 (estropipate).
Ogen 0.625 disease interactions
There are 17 disease interactions with Ogen 0.625 (estropipate) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Ogen 0.625 (estropipate)
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.